Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Abstract Background The optimal definitive chemotherapy regimen during concurrent chemoradiotherapy (CRT) for patients with advanced esophageal squamous cell carcinoma (ESCC) remains unclear because of conflicting evidence. This study aimed to compare the effectiveness of taxane‐based chemotherapy w...

Full description

Bibliographic Details
Main Authors: Jason Chia‐Hsun Hsieh, Pin‐Chun Chiang, Tsung‐Min Hung, Yin‐Kai Chao, Yung‐Chia Kuo, Chih‐Tsung Wen, Po‐Jung Su, Meng‐Ting Peng, Huan‐Wu Chen, Hui‐Ling Liu, Hsien‐Kun Chang, Min‐Hsien Wu, Hung‐Ming Wang
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Cancer Medicine
Subjects:
5‐fluorouracil
carboplatin
cisplatin
definitive chemoradiotherapy
esophageal squamous cell carcinoma
paclitaxel
Online Access:https://doi.org/10.1002/cam4.4025

Internet

https://doi.org/10.1002/cam4.4025

Similar Items